Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/3898
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | THEOBALDO, Mariana Cardillo | - |
dc.contributor.author | LLIMONA, Flavia | - |
dc.contributor.author | PETRONI, Ricardo Costa | - |
dc.contributor.author | RIOS, Ester Correia Sarmento | - |
dc.contributor.author | VELASCO, Irineu Tadeu | - |
dc.contributor.author | SORIANO, Francisco Garcia | - |
dc.date.accessioned | 2014-01-28T22:17:17Z | - |
dc.date.available | 2014-01-28T22:17:17Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | PLOS ONE, v.8, n.9, article ID e74369, 9p, 2013 | - |
dc.identifier.issn | 1932-6203 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/3898 | - |
dc.description.abstract | The effects of hypertonic saline solution (HSS) have been shown in several animal models of ischemia and shock. Literature has shown potential benefits of HSS modulating inflammatory response after sepsis in an animal model. We studied the HSS effects in sepsis through cecal ligation and puncture (CLP) in Balb-C mice. Groups studied: 1-CLP without treatment (CLP-C); 2-CLP treated with normal saline solution NaCl 0.9% - 34 ml/Kg (CLP-S); 3-CLP treated with HSS NaCl 7.5% - 4 ml/Kg (CLPH); and 4-group (Basal) without no CLP or treatment. Volume infusion was always applied 30 min after CLP. Lung and peritoneal lavage were harvested after 6h and 24h of CLP to analyze cytokines amount, oxide nitric, lipid peroxidation and neutrophil infiltration. Neutrophil infiltration, ICAM-1, CXCR-2, and CXCL-1 in lung were reduced by HSS (CLP-H) compared to CLP-C or CLP-S. Neutrophil in peritoneal lavage was increased in 24h with HSS (CLP-H) compared to CLP and CLP-S. Peritoneal CXCR-2 was increased in CLP-C and CLP-S but presented a lower increase with HSS (CLP-H) after 6 hours. GRK-2 presented difference among the groups at 24 h, showing a profile similar to neutrophil infiltration. Pro-inflammatory cytokines (TNF-alpha and IL-6) were reduced by HSS treatment; CLP-S increased TNF-alpha IL-10 was increased in lung tissue by the HSS treatment. The oxidative stress (TBARS and nitric oxide biochemistry markers) was reduced with HSS. Animal survival was 33.3% in CLP-C group, 46.6% in CLP-S group and 60% in the CLP-H group after the sixth day. The HSS protects the animal against sepsis. Our results suggest that the volume replacement modulate pro and anti-inflammatory mediators of an inflammatory response, but HSS presented a more effective and potent effect. | - |
dc.description.sponsorship | FAPESP [2009/15530-0] | - |
dc.language.iso | eng | - |
dc.publisher | PUBLIC LIBRARY SCIENCE | - |
dc.relation.ispartof | Plos One | - |
dc.rights | openAccess | - |
dc.subject.other | severe hemorrhagic-shock | - |
dc.subject.other | septic shock | - |
dc.subject.other | injury | - |
dc.subject.other | resuscitation | - |
dc.subject.other | mortality | - |
dc.subject.other | survival | - |
dc.subject.other | mice | - |
dc.subject.other | pathophysiology | - |
dc.subject.other | epidemiology | - |
dc.subject.other | pathogenesis | - |
dc.title | Hypertonic Saline Solution Drives Neutrophil from Bystander Organ to Infectious Site in Polymicrobial Sepsis: A Cecal Ligation and Puncture Model | - |
dc.type | article | - |
dc.rights.holder | Copyright PUBLIC LIBRARY SCIENCE | - |
dc.identifier.doi | 10.1371/journal.pone.0074369 | - |
dc.identifier.pmid | 24069301 | - |
dc.subject.wos | Multidisciplinary Sciences | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.description.articlenumber | e74369 | - |
hcfmusp.description.issue | 9 | - |
hcfmusp.description.volume | 8 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | 2-s2.0-84884275205 | - |
hcfmusp.origem.id | WOS:000324547300037 | - |
hcfmusp.publisher.city | SAN FRANCISCO | - |
hcfmusp.publisher.country | USA | - |
hcfmusp.relation.reference | Abraham E, 1999, INTENS CARE MED, V25, P556, DOI 10.1007/s001340050903 | - |
hcfmusp.relation.reference | ALBELDA SM, 1994, FASEB J, V8, P504 | - |
hcfmusp.relation.reference | Alberti C, 2002, INTENS CARE MED, V28, P108, DOI 10.1007/s00134-001-1143-z | - |
hcfmusp.relation.reference | Alves JC, 2008, SHOCK, V30, P3, DOI 10.1097/SHK.0b013e3181818466 | - |
hcfmusp.relation.reference | Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI 10.1097/00003246-200107000-00002 | - |
hcfmusp.relation.reference | BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644 | - |
hcfmusp.relation.reference | Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326 | - |
hcfmusp.relation.reference | Conde KA, 2013, PLOS ONE, V6 | - |
hcfmusp.relation.reference | Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300 | - |
hcfmusp.relation.reference | Dal-Pizzol F, 2006, AM J RESP CRIT CARE, V173, P84, DOI 10.1164/rccm.200507-1118OC | - |
hcfmusp.relation.reference | da Silva FP, 2009, FRONT BIOSCI, V14, P4464, DOI 10.2741/3542 | - |
hcfmusp.relation.reference | Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S | - |
hcfmusp.relation.reference | Frazier WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050071 | - |
hcfmusp.relation.reference | Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045 | - |
hcfmusp.relation.reference | GLAUSER MP, 1994, CLIN INFECT DIS, V18, pS205 | - |
hcfmusp.relation.reference | HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869 | - |
hcfmusp.relation.reference | HOLZHEIMER RG, 1991, INFECTION, V19, P447, DOI 10.1007/BF01726463 | - |
hcfmusp.relation.reference | Leendertse M, 2009, INFECT IMMUN, V77, P485, DOI 10.1128/IAI.00863-08 | - |
hcfmusp.relation.reference | Majcherczyk PA, 1999, J BIOL CHEM, V274, P12537, DOI 10.1074/jbc.274.18.12537 | - |
hcfmusp.relation.reference | Malbrain MLNG, 2005, CURR OPIN CRIT CARE, V11, P156, DOI 10.1097/01.ccx.0000155355.86241.1b | - |
hcfmusp.relation.reference | Melo ES, 2010, MOL IMMUNOL, V47, P2587, DOI 10.1016/j.molimm.2010.06.011 | - |
hcfmusp.relation.reference | MercerJones MA, 1997, SHOCK, V8, P193, DOI 10.1097/00024382-199709000-00007 | - |
hcfmusp.relation.reference | Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393 | - |
hcfmusp.relation.reference | Nduka OO, 2009, CRIT CARE CLIN, V25, P677, DOI 10.1016/j.ccc.2009.08.002 | - |
hcfmusp.relation.reference | Noppens RR, 2012, CRIT CARE MED, V40, P2149, DOI 10.1097/CCM.0b013e31824e6750 | - |
hcfmusp.relation.reference | Oliveira RP, 2002, CRIT CARE, V6, P418 | - |
hcfmusp.relation.reference | Petroni RC, 2012, SHOCK, V37, P524, DOI 10.1097/SHK.0b013e31824c7665 | - |
hcfmusp.relation.reference | Remick DG, 1998, CRIT CARE MED, V26, P895, DOI 10.1097/00003246-199805000-00025 | - |
hcfmusp.relation.reference | Rios ECS, 2011, CLINICS, V66, P469, DOI 10.1590/S1807-59322011000300019 | - |
hcfmusp.relation.reference | Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542 | - |
hcfmusp.relation.reference | Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307 | - |
hcfmusp.relation.reference | SILVA MRF, 1987, AM J PHYSIOL, V253, pH751 | - |
hcfmusp.relation.reference | Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777 | - |
hcfmusp.relation.reference | Soriano FG, 2002, SHOCK, V17, P286, DOI 10.1097/00024382-200204000-00008 | - |
hcfmusp.relation.reference | Soriano FG, 2001, CRIT CARE MED, V29, P703 | - |
hcfmusp.relation.reference | Soriano FG, 2011, SHOCK, V35, P560, DOI 10.1097/SHK.0b013e31820fe5d5 | - |
hcfmusp.relation.reference | Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3 | - |
hcfmusp.relation.reference | van Haren FMP, 2012, SHOCK, V37, P268, DOI 10.1097/SHK.0b013e31823f152f | - |
hcfmusp.relation.reference | VELASCO IT, 1989, CRIT CARE MED, V17, P261, DOI 10.1097/00003246-198903000-00012 | - |
hcfmusp.relation.reference | VELASCO IT, 1980, AM J PHYSIOL, V239, pH664 | - |
hcfmusp.relation.reference | WEISS SJ, 1989, NEW ENGL J MED, V320, P365 | - |
hcfmusp.relation.reference | Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564 | - |
hcfmusp.relation.reference | ZAPATASIRVENT RL, 1995, BURNS, V21, P185, DOI 10.1016/0305-4179(95)80006-A | - |
dc.description.index | MEDLINE | - |
hcfmusp.remissive.sponsorship | FAPESP | - |
hcfmusp.citation.scopus | 12 | - |
hcfmusp.scopus.lastupdate | 2022-06-02 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCM Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - HC/InCor Artigos e Materiais de Revistas Científicas - LIM/51 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_THEOBALDO_Hypertonic_Saline_Solution_Drives_Neutrophil_from_Bystander_Organ_2013.PDF | publishedVersion (English) | 1.13 MB | Adobe PDF | ![]() View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.